肝硬化患者经口内镜下肌切开术的多中心结局
该多中心回顾性研究纳入2020至2024年间6家美国三级中心接受POEM的24例肝硬化患者,全部完成肌切开且无术中或迟发性静脉曲张出血、输血或术后肝失代偿;21例有随访Eckardt评分者中18例(85.7%)临床改善,提示在高选择患者中POEM可行且能改善症状。
要点
- 肝硬化患者POEM技术成功率高,本组24例全部完成肌切开。
- 未观察到静脉曲张出血、输血或术后肝失代偿。
- 21例随访者中18例(85.7%)Eckardt评分改善。
核心结论
- 在高选择、经验丰富中心治疗的肝硬化患者中,POEM可行且与症状改善相关,未观察到重大出血。
- 作者指出这些结果代表早期经验,应谨慎解读。
研究设计与样本
- 多中心回顾性研究,纳入2020至2024年间6家美国三级中心接受POEM的肝硬化患者24例(平均年龄67.5岁,女性10例)。
- 技术成功定义为完成肌切开且无中转或重大术中出血;临床成功定义为6个月Eckardt评分≤3。
主要发现
- 24例POEM全部成功完成。
- 未观察到术中或迟发性静脉曲张出血、输血或手术相关肝失代偿。
- 21例有随访Eckardt评分,其中18例(85.7%)显示临床改善。
关键数值与推荐
- 技术成功:完成肌切开且无中转或重大术中出血。
- 临床成功:6个月Eckardt评分≤3。
- 随访Eckardt评分可获取者21例,18例(85.7%)临床改善。
临床怎么用
- 对于经选择的肝硬化合并食管动力障碍患者,在有经验的中心可考虑POEM,但需个体化评估门脉高压和出血风险。
- 术后应关注Eckardt评分以评估临床反应。
局限性
- 回顾性设计,样本量小(24例),随访Eckardt评分仅21例可获取。
- 患者高度选择且均在经验丰富中心治疗,结果外推需谨慎。
- 作者明确表示这些发现代表早期经验,应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with cirrhosis and esophageal motility disorders are frequently excluded from peroral endoscopic myotomy (POEM) because of concerns related to portal hypertension and bleeding risk. As a result, data on POEM in this population are limited. We describe a multicenter experience evaluating the feasibility and short-term outcomes of POEM in patients with cirrhosis. METHODS: We retrospectively reviewed patients with cirrhosis who underwent POEM at 6 U.S. tertiary centers between 2020 and 2024. Technical success was defined as completion of the myotomy without conversion or major intraprocedural bleeding. Clinical success was defined as a 6-month Eckardt score ≤3. RESULTS: Twenty-four patients (mean age, 67.5 years; 10 females) underwent POEM, all of which were completed successfully. No intraprocedural or delayed variceal bleeding, transfusions, or procedure-related hepatic decompensation were observed. Follow-up Eckardt scores were available for 21 patients, of whom 18 (85.7%) demonstrated clinical improvement. CONCLUSIONS: In this highly selected cohort treated at experienced centers, POEM was feasible and associated with symptomatic improvement without observed major bleeding. These findings represent an early experience and should be interpreted cautiously.
引用
- Butt MA, Mirminachi B, Cifuentes L, et al. Outcomes of peroral endoscopic myotomy in patients with cirrhosis: a multicenter experience. Gastrointest Endosc. 2026. PMID: 41903820. doi:10.1016/j.gie.2026.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。